Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ciprofloxacin hydrochloride
Drug ID BADD_D00472
Description Ciprofloxacin is a second generation fluoroquinolone that has spawned many derivative antibiotics.[A178870] It is formulated for oral, intravenous, intratympanic, ophthalmic, and otic administration for a number of bacterial infections.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493] The first ciprofloxacin containing product was FDA approved on 22 October 1987.[L6463]
Indications and Usage For the treatment of the following infections caused by susceptible organisms: urinary tract infections, acute uncomplicated cystitis, chronic bacterial prostatitis, lower respiratory tract infections, acute sinusitis, skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections (used in combination with metronidazole), infectious diarrhea, typhoid fever (enteric fever), uncomplicated cervical and urethral gonorrhea, and inhalational anthrax (post-exposure).
Marketing Status Prescription; Discontinued
ATC Code J01MA02; S01AE03; S02AA15; S03AA07
DrugBank ID DB00537
KEGG ID D02216
MeSH ID D002939
PubChem ID 62999
TTD Drug ID D0O1WX
NDC Product Code 50090-3791; 17478-714; 43063-923; 68999-309; 70518-1278; 70518-1234; 50090-5628; 63187-150; 59390-217; 68071-2382; 62135-308; 52286-0005; 0078-0841; 50090-5671; 61442-222; 68788-8136; 53069-0180; 48589-0001; 51943-112; 45865-721; 12527-8513; 50419-754; 16714-653; 62704-0030; 53002-1320; 65862-076; 71901-602; 72789-006; 51672-4085; 50090-0881; 63629-8344; 50090-3130; 61314-656; 62991-2518; 38779-0534; 76420-045; 0065-0656; 63629-1010; 71610-159; 63629-7648; 50090-5373; 50090-5371; 70934-093; 68071-4139; 58032-0006; 72189-111; 52286-0015; 71335-2046; 65862-077; 62135-310; 16714-652; 66021-0003; 71335-1024; 49452-2080; 0404-7187; 55700-884; 50090-4600; 63739-559; 50090-2146; 61442-223; 55154-2081; 65862-078; 45865-877; 71335-0836; 16714-651; 62135-309; 50090-1754; 53104-7518; 68084-070; 68071-4492; 51672-4087; 71335-1347; 50090-3852; 63629-7717; 71205-997; 68071-2440; 71610-109; 51927-0236; 51672-4086; 68071-4576; 68071-3351; 71205-536; 71205-636; 68071-2290; 67296-1696; 50419-758; 12527-8512; 55154-8148; 68071-4627; 63739-700; 55111-010; 71205-649; 72789-065; 61442-224; 55154-2086; 63187-985; 65862-379; 51407-165; 53002-9320
Synonyms Ciprofloxacin | Ciprofloxacin Hydrochloride Anhydrous | Anhydrous, Ciprofloxacin Hydrochloride | Hydrochloride Anhydrous, Ciprofloxacin | Cipro | Ciprofloxacin Hydrochloride | Hydrochloride, Ciprofloxacin | Ciprofloxacin Monohydrochloride Monohydrate | Monohydrate, Ciprofloxacin Monohydrochloride | Monohydrochloride Monohydrate, Ciprofloxacin | Bay-09867 | Bay 09867 | Bay09867 | Ciprinol
Chemical Information
Molecular Formula C17H19ClFN3O3
CAS Registry Number 86483-48-9
SMILES C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Acute hepatic failureAlanine aminotransferase 1P24298Not AvailableNot Available
Acute hepatic failureAspartate aminotransferase, mitochondrialP00505Not AvailableNot Available
DeathDNA gyrase subunit AP48369Not AvailableNot Available
HaematotoxicityAlanine aminotransferase 1P24298Not AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal pain07.01.05.002--
Acidosis14.01.03.002--
Ageusia17.02.07.001; 07.14.03.003--Not Available
Agitation17.02.05.012; 19.06.02.001--
Agranulocytosis01.02.03.001--Not Available
Alanine aminotransferase increased13.03.01.003--
Albuminuria20.02.01.001--Not Available
Amylase increased13.05.01.009--
Anaemia01.03.02.001--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angina pectoris24.04.04.002; 02.02.02.002--
Angioedema23.04.01.001; 10.01.05.009--Not Available
Anosmia22.04.03.006; 17.04.04.001--
Arthralgia15.01.02.001--
Aspartate aminotransferase13.03.01.032--Not Available
Asthenia08.01.01.001--Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Ataxia17.02.02.001; 08.01.02.004--
Atrial flutter02.03.03.003--
Back pain15.03.04.005--
Blood alkaline phosphatase13.04.02.010--Not Available
Blood bilirubin13.03.01.040--Not Available
Blood cholesterol increased13.12.01.002--
Blood creatinine increased13.13.01.004--
Blood glucose13.02.02.009--Not Available
Blood glucose increased13.02.02.002--Not Available
Blood lactate dehydrogenase13.04.02.009--Not Available
Blood potassium increased13.11.01.011--Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 7 Pages